Kezar Appoints Courtney Wallace to its Board of Directors
Kezar Life Sciences Announces Interim Results from the MISSION Phase 2 Trial in Patients with Lupus Nephritis
Kezar Life Sciences to Present at the Jefferies London Healthcare Conference
Kezar Reports Third Quarter Financial Results and Provides Business Update
Kezar to Host Virtual Investor and Analyst Day on November 15, 2021
